434P CodeBreaK 101 subprotocol H: Phase Ib study evaluating combination of sotorasib (Soto), a KRASG12C inhibitor, and panitumumab (PMab), an EGFR inhibitor, in advanced KRAS p.G12C-mutated colorectal cancer (CRC)
Fakih, M., Falchook, G.S., Hong, D.S., Yaeger, R.D., Chan, E., Mather, O., Cardona, P., Dai, T., Strickler, J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
PD-0646 Outcomes of stereotactic radiosurgery for colorectal cancer brain metastases
Gui, C., Mueller, K.D., Eichholz, J.E., Walch, H., Khatri, I., del Balzo, L., Kemeny, N.E., Imber, B.S., Schultz, N., Foote, M.B., Yaeger, R.D., Pike, L.R.G.
Published in Radiotherapy and oncology (01.05.2023)
Published in Radiotherapy and oncology (01.05.2023)
Get full text
Journal Article
LBA6 KRYSTAL-1: Adagrasib (MRTX849) as monotherapy or combined with cetuximab (Cetux) in patients (Pts) with colorectal cancer (CRC) harboring a KRASG12C mutation
Weiss, J., Yaeger, R.D., Johnson, M.L., Spira, A., Klempner, S.J., Barve, M.A., Christensen, J.G., Chi, A., Der-Torossian, H., Velastegui, K., Kheoh, T., Ou, S-H.I.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article